Neurobit

📍 New York, United States🗓 Founded 2018👥 28 employees💰 Last funded Mar 2019
Every year over 26 million suffer heart failure, 15 million suffer a stroke and 10 million develop dementia. Most of these incidents can be predicted years before they happen. Neurobit uses physiological signals collected during sleep to uncover these patterns. Using sleep as a biomarker, Neurobit is building a Universal health analytics platform with their state-of-the-art AI models, trained on over a trillion data points of multi-channel physiological data to operate across devices, signals and disease conditions. Neurobit's technologies are trusted by 120+ universities, hospitals and R&D centers from across the world. Contact us to find out how our technologies can help you improve care and deliver better outcomes.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Singapore
1
Frequently asked questions
Who invested in Neurobit?
Neurobit has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Neurobit last raise funding?
The most recent investment in Neurobit recorded on gritt.io was in March 2019.
When was Neurobit founded?
Neurobit was founded in 2018.
What industry is Neurobit in?
Neurobit operates in Home Health Care Services. Find similar Home Health Care Services investors on gritt.io.
Where is Neurobit based?
Neurobit is headquartered in New York, United States.